Breaking News Instant updates and real-time market news.

FOLD

Amicus

$5.98

-0.53 (-8.14%)

12:40
12/01/16
12/01
12:40
12/01/16
12:40

Massive deep put trade in Amicus Therapeutics looks closing

Massive deep put trade in Amicus Therapeutics looks closing. Customer paid $4.20 for 28K Jan 10 puts tied to 2.8M shares at $5.925. Appears to close most of the put open interest in the name. 34K contracts have been opened since early October in the $3.40 price range. Shares have seen an impressive range over the past 8 weeks, dipping below $6 Nov 3rd and nearly hitting $10 two weeks later.

FOLD Amicus
$5.98

-0.53 (-8.14%)

07/20/16
JPMS
07/20/16
NO CHANGE
Target $13
JPMS
Overweight
Amicus risk/reward 'compelling' at current levels, says JPMorgan
JPMorgan analyst Anupam Rama views the risk/reward for shares of Amicus Therapeutics at current levels as "compelling." After declining 39% year-to-date, Amicus is essentially only pricing in outside the U.S. Galafold sales in Fabry disease plus cash, Rama tells investors in a research note. Very little credit is being given to the company's U.S. migalastat, Zorblisa or the Pompe program, which all have events in the second half of 2016, the analyst contends. Rama thinks only one of the three need to hit for the stock to trade "materially higher," with upside ranging from 20%-100%-plus on a single success, and "meaningfully more upside" potential on multiple positive updates. Rama reiterates an Overweight rating on Amicus with a $13 price target.
08/22/16
GSCO
08/22/16
NO CHANGE
GSCO
Goldman lists companies to be in focus after Medivation deal
After Pfizer (PFE) announced it has agreed to acquire Medivation (MDVN) for $81.50 per share in cash, Goldman Sachs analyst Salveen Richter said he expects a focus on other commercial small-to-mid-cap cancer companies, including Incyte (INCY), Seattle Genetics (SGEN), ARIAD (ARIA) and Exelixis (EXEL). Also noting that Sanofi (SNY), which was pursuing Medivation, has recently suggested an interest in a rare disease transaction up to potentially as large as $20B, he would expect rare disease companies of that size - such as BioMarin (BMRN), Amicus (FOLD) and Ultragenyx (RARE) - to be in focus as well.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
11/29/16
COWN
11/29/16
NO CHANGE
Target $12
COWN
Outperform
Amicus price target lowered to $12 from $15 at Cowen
Cowen analyst Ritu Baral lowered her price target on Amicus to $12 from $15 after the FDA told the company it could not file the Galafold NDA with current data and that data from a new trial is expected in 2019. Baral maintained her Outperform rating on Amicus, stating that the planned GI trial has a good chance of success.

TODAY'S FREE FLY STORIES

ANET

Arista Networks

$121.35

-1.27 (-1.04%)

11:07
02/22/17
02/22
11:07
02/22/17
11:07
Conference/Events
Arista Networks management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 27

    Feb

  • 03

    Mar

  • 13

    Mar

  • 14

    Mar

FB

Facebook

$133.72

0.19 (0.14%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Hot Stocks
Instagram announces update allowing sharing of multiple photos in one post »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

WMAR

West Marine

$9.15

-0.01 (-0.11%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Conference/Events
West Marine management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

AAP

Advance Auto Parts

$157.00

-4.155 (-2.58%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Options
Advance Auto Parts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$43.28

0.13 (0.30%)

11:05
02/22/17
02/22
11:05
02/22/17
11:05
Conference/Events
TD Ameritrade management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

AMD

AMD

$14.00

0.87 (6.63%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Conference/Events
AMD management to meet with Canaccord »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MOBL

MobileIron

$4.90

0.15 (3.16%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Hot Stocks
MobileIron forms Internet of Things division »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MOBL

MobileIron

$4.90

0.15 (3.16%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Hot Stocks
MobileIron forms Internet of Things division »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AMD

AMD

$14.00

0.87 (6.63%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Technical Analysis
AMD ticks fresh multi-year and 52-week high »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MRVL

Marvell

$16.21

0.4 (2.53%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Conference/Events
Marvell management to meet with B. Riley »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 10

    Mar

  • 04

    Apr

  • 05

    Apr

SQ

Square

$14.70

0.07 (0.48%)

, AAPL

Apple

$136.70

0.98 (0.72%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Earnings
On The Fly: What to watch in Square earnings report »

Square (SQ) is scheduled…

SQ

Square

$14.70

0.07 (0.48%)

AAPL

Apple

$136.70

0.98 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 13

    Mar

CWBC

Community West Bancshares

$10.13

0.0252 (0.25%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Hot Stocks
Community West Bancshares says CFO Baltuskonis to retire July 2017 »

Community West Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$71.36

-0.06 (-0.08%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Conference/Events
Aflac management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 05

    Mar

ARGS

Argos Therapeutics

$4.40

-0.3 (-6.38%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Downgrade
Argos Therapeutics rating change  »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Apr

CPB

Campbell Soup

$59.42

0.47 (0.80%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Hot Stocks
Campbell Soup CEO repeats plan to achieve $300M in cost savings by end of FY17 »

Campbell Soup CEO Denise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TSO

Tesoro

$88.39

-0.69 (-0.77%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Options
Tesoro put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$14.00

0.87 (6.63%)

, INTC

Intel

$36.52

0.04 (0.11%)

10:53
02/22/17
02/22
10:53
02/22/17
10:53
Periodicals
AMD looks to challenge Intel's PC processor dominance, FT says »

With a new type of…

AMD

AMD

$14.00

0.87 (6.63%)

INTC

Intel

$36.52

0.04 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 27

    Feb

  • 19

    Mar

  • 04

    Apr

  • 05

    Apr

CEO

CNOOC

$121.51

-1.14 (-0.93%)

10:52
02/22/17
02/22
10:52
02/22/17
10:52
Recommendations
CNOOC analyst commentary  »

CNOOC named a long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QVCA

Liberty Interactive

$19.71

0.41 (2.12%)

10:51
02/22/17
02/22
10:51
02/22/17
10:51
Technical Analysis
Liberty Interactive spikes higher on very heavy volume »

The stock has spiked,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$22.25

0.47 (2.16%)

10:48
02/22/17
02/22
10:48
02/22/17
10:48
Options
Under Armour calls active as shares tick higher »

Under Armour calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAT

Brinker

$42.55

-1.32 (-3.01%)

10:45
02/22/17
02/22
10:45
02/22/17
10:45
Conference/Events
Brinker management to meet with Maxim »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    May

KR

Kroger

$33.05

-1.175 (-3.43%)

10:41
02/22/17
02/22
10:41
02/22/17
10:41
Options
Pre-earnings jitters in Kroger as shares slide »

Pre-earnings jitters in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$108.18

-1.495 (-1.36%)

10:39
02/22/17
02/22
10:39
02/22/17
10:39
Hot Stocks
Breaking Hot Stocks news story on Union Pacific »

Union Pacific says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 09

    May

ECPG

Encore Capital

10:38
02/22/17
02/22
10:38
02/22/17
10:38
Periodicals
Cabot Credit considering London stock listing, Sky News reports »

Shareholders in Cabot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

UNP

Union Pacific

$108.18

-1.49 (-1.36%)

10:38
02/22/17
02/22
10:38
02/22/17
10:38
Hot Stocks
Breaking Hot Stocks news story on Union Pacific »

Union Pacific says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.